Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 5,490 shares at $10.00 ($55K) on 2017-09-05, disclosed to the SEC on 2017-09-06.
Open-market sale of $55k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2018-02-13 | $45K | — | Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |